Commentator Discussion: Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy
J Thorac Cardiovasc Surg
.
2025 Apr;169(4):1096-1097.
doi: 10.1016/j.jtcvs.2024.11.007.
Epub 2024 Dec 20.
PMID:
39708005
DOI:
10.1016/j.jtcvs.2024.11.007
No abstract available